Carpal Tunnel Syndrome Injections: PRP vs Steroid vs Dextrose Prolotherapy
- 2 days ago
- 4 min read
By Dr. Jeffrey Peng, MD · Published March 5, 2026 · 5 min read
Watch the Full Video
Carpal tunnel syndrome is one of the most common causes of hand pain and numbness, affecting millions of people each year. Injections are frequently used to provide symptom relief, but which type of injection delivers the best results? A systematic review and network meta-analysis compared three injection options — platelet-rich plasma (PRP), dextrose prolotherapy, and corticosteroids — to determine which treatment produces the best outcomes.
What Are the Injection Options for Carpal Tunnel Syndrome?
When conservative measures like wrist splinting and activity modification are not enough, injections can offer meaningful relief. The three most studied injectable treatments for carpal tunnel syndrome are corticosteroids, platelet-rich plasma, and dextrose prolotherapy. Each works through a different mechanism, and understanding those differences can help guide treatment decisions.
How Do Corticosteroid Injections Work?
Corticosteroid injections have been the standard injection treatment for carpal tunnel syndrome for decades. They work by suppressing inflammation around the median nerve within the carpal tunnel, which can reduce swelling and alleviate symptoms. However, there are growing concerns about their limited duration of effect and potential side effects with repeated use, including tendon weakening and local tissue atrophy.
What Is PRP and How Does It Help Carpal Tunnel Syndrome?
PRP, or platelet-rich plasma, is a regenerative injection that uses a concentrated preparation of the patient's own platelets. These platelets release growth factors that stimulate tissue healing and reduce inflammation. Because PRP is derived from the patient's own blood, it carries a very low risk of adverse reactions. In the context of carpal tunnel syndrome, PRP may promote nerve healing and reduce the inflammatory environment compressing the median nerve.
What Is Dextrose Prolotherapy?
Dextrose prolotherapy involves injecting a solution of concentrated dextrose (a sugar similar to glucose) around the affected area. The goal is to stimulate the body's natural healing response and improve tissue function. Dextrose prolotherapy has been used for over 70 years in the treatment of chronic pain conditions and, like PRP, has an excellent safety profile with virtually no significant side effects.
Which Injection Works Best? What the Research Shows
A 2022 systematic review and network meta-analysis by Gao et al. examined 12 randomized controlled trials comparing corticosteroid, PRP, and dextrose prolotherapy injections for carpal tunnel syndrome (Gao et al., 2022). The study included 749 patients and 817 hands.
The authors used SUCRA scores (Surface Under the Cumulative Ranking Curve) to rank each treatment. A higher SUCRA score indicates a more favorable ranking. The results showed that PRP injections had the highest SUCRA scores across all three outcome measures: symptom relief (91.5%), functional improvement (92.7%), and pain reduction (80.8%). Dextrose prolotherapy ranked second, with scores of 74.4%, 72.2%, and 72.1% respectively. Corticosteroid injections ranked last among the three active treatments, with scores of 33.7%, 31.9%, and 46.2%. All three injectable treatments were significantly more effective than placebo.
Does PRP Always Beat Dextrose Prolotherapy?
While the overall SUCRA rankings favor PRP, a closer look at the individual outcome measures reveals a more nuanced picture. When examining carpal tunnel syndrome severity scores specifically, there was no statistically significant difference between dextrose prolotherapy and PRP, though both outperformed corticosteroids. For functional status scores, PRP was superior to corticosteroids, but dextrose prolotherapy was not — and importantly, PRP and dextrose prolotherapy were not statistically different from each other. For pain scores measured by visual analog scale, there were no significant differences among any of the three treatments.
Adding further complexity, an earlier network meta-analysis by Lin et al. actually found that dextrose prolotherapy ranked higher than PRP for symptom relief (Lin et al., 2020). That study also concluded that the effects of corticosteroid injections were temporary and less effective than both PRP and dextrose prolotherapy.
Which Injection Should You Choose?
In my practice, I generally recommend dextrose prolotherapy over PRP injections for carpal tunnel syndrome at this time, primarily because of cost. Dextrose is significantly less expensive than PRP, and given that the clinical outcomes appear similar between the two treatments, it makes sense to start with the more affordable option — especially when both have the same excellent safety profile.
If insurance coverage for PRP improves in the future, it may become the preferred first-line regenerative injection, since the overall data suggests PRP may be slightly more effective. However, more research is needed to determine which treatment is definitively superior in the long term.
Regardless of which injection you receive, it is critical to pair the treatment with a structured exercise program focused on stretching and strengthening of the wrist and hand. Injections alone are rarely a complete solution — they work best as part of a comprehensive treatment plan.
If you are experiencing symptoms of carpal tunnel syndrome and would like to explore injection options, schedule a consultation to discuss which treatment approach may be right for you.
References
1. Gao N, Yan L, Ai F, et al. Comparison of the Short-Term Clinical Effectiveness of 5% Dextrose Water, Platelet-rich Plasma and Corticosteroid Injections for Carpal Tunnel Syndrome: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials. Arch Phys Med Rehabil. 2022;104(5):799-811. doi:10.1016/j.apmr.2022.11.009
2. Lin CP, Chang KV, Huang YK, Wu WT, Özçakar L. Regenerative Injections Including 5% Dextrose and Platelet-Rich Plasma for the Treatment of Carpal Tunnel Syndrome: A Systematic Review and Network Meta-Analysis. Pharmaceuticals (Basel). 2020;13(3):49. doi:10.3390/ph13030049
Medical Disclaimer: This content is for educational purposes only and does not substitute for the medical advice of a physician. Always consult your healthcare provider before beginning any new treatment program. The information presented reflects the opinion of Dr. Jeffrey Peng and does not represent the views of his employers or affiliated hospital systems.
Comments